Timothy Mark Willson
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Biochemistry top 0.01%
Papers in
-
- Peroxisome Proliferator-Activated Receptors 86
- Oncology 71
- Drug Transport and Resistance Mechanisms 53
- Co-authors
- Steven A. Kliewer (43 shared papers)Jürgen M. Lehmann (16 shared papers)Linda B. Moore (24 shared papers)Christopher K. Glass (7 shared papers)Millard H. Lambert (27 shared papers)Stacey A. Jones (15 shared papers)Andrew C. Li (5 shared papers)Bryan J. Goodwin (14 shared papers)
- Journals
- Journal of Medicinal Chemistry (38 papers)Journal of Biological Chemistry (23 papers)Bioorganic & Medicinal Chemistry Letters (15 papers)Proceedings of the National Academy of Sciences (12 papers)Molecular Endocrinology (10 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Timothy Mark Willson
258 papers receiving 57.9k citations
Timothy Mark Willson's Hit Papers
Peers
Comparison fields: 5 of 184
- Pharmacology 7.3k
- Biochemistry 4.5k
- Oncology 13.8k
- Molecular Biology 32.8k
- Endocrinology, Diabetes and Metabolism 6.1k
Countries citing papers authored by Timothy Mark Willson
This map shows the geographic impact of Timothy Mark Willson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Mark Willson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Mark Willson more than expected).
Fields of papers citing papers by Timothy Mark Willson
This network shows the impact of papers produced by Timothy Mark Willson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Mark Willson. The network helps show where Timothy Mark Willson may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy Mark Willson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) Hit paper breakdown → | 1995 | 3251 |
| 2 | The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Hit paper breakdown → | 1998 | 3211 |
| 3 | Bile Acids: Natural Ligands for an Orphan Nuclear Receptor Hit paper breakdown → | 1999 | 1990 |
| 4 | Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Hit paper breakdown → | 1997 | 1899 |
| 5 | A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation Hit paper breakdown → | 1995 | 1839 |
| 6 | Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ Hit paper breakdown → | 1998 | 1721 |
| 7 | A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid Biosynthesis Hit paper breakdown → | 2000 | 1671 |
| 8 | The PPARs: From Orphan Receptors to Drug Discovery Hit paper breakdown → | 2000 | 1618 |
| 9 | The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Hit paper breakdown → | 1998 | 1390 |
| 10 | An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway Hit paper breakdown → | 1998 | 1344 |
| 11 | The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity Hit paper breakdown → | 2001 | 1199 |
| 12 | A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ Hit paper breakdown → | 2005 | 1079 |
| 13 | Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway Hit paper breakdown → | 1997 | 1051 |
| 14 | Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptors Hit paper breakdown → | 1999 | 986 |
| 15 | A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport Hit paper breakdown → | 2001 | 917 |
| 16 | Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice Hit paper breakdown → | 2006 | 826 |
| 17 | Synthetic LXR ligand inhibits the development of atherosclerosis in mice Hit paper breakdown → | 2002 | 816 |
| 18 | St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Hit paper breakdown → | 2000 | 789 |
| 19 | Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase Hit paper breakdown → | 1999 | 779 |
| 20 | The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism Hit paper breakdown → | 2002 | 776 |
About Timothy Mark Willson
Timothy Mark Willson is a scholar working on Molecular Biology, Oncology, Pharmacology, Genetics and Cancer Research, having authored 263 papers that have together received 60.1k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (86 papers), Drug Transport and Resistance Mechanisms (53 papers), Estrogen and related hormone effects (48 papers), Cholesterol and Lipid Metabolism (41 papers), Pharmacogenetics and Drug Metabolism (25 papers), Adipose Tissue and Metabolism (24 papers), Inflammatory mediators and NSAID effects (23 papers) and Computational Drug Discovery Methods (22 papers). The work is most often cited by research in Pharmacology (7.3k citations), Biochemistry (4.5k citations), Oncology (13.8k citations), Molecular Biology (32.8k citations) and Endocrinology, Diabetes and Metabolism (6.1k citations). Timothy Mark Willson has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Steven A. Kliewer, Jürgen M. Lehmann, Linda B. Moore, Christopher K. Glass, Millard H. Lambert, Stacey A. Jones, Andrew C. Li, Bryan J. Goodwin, John T. Moore and David D. McKee. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences and Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.